pharmacotherapy of depression Flashcards

1
Q

what are pathologies related to depression

A

Stroke
Chronic pain syndrome: Fibromyalgia, Low back pain / Chronic pelvic pain, Bone or disease related pain
Multiple sclerosis
Hypo / hyperthyroidism
Traumatic Brain Injury (TBI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DSM-5 diagnostic criteria

A

At least one of the symptoms must be depressed mood or
loss of interest or pleasure in doing things

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Recurrence

A

risk becomes lower over time as duration of remission increases
persistent mild symptoms during remission is a predictor of recurrence
function deteriorates during the episode and goes back to baseline upon remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is SIGE CAPS

A

Sleep (insomnia/hypersomnia
Interest decreased (anhedonia)
Guilt/worthlessness
Energy loss/fatigue
Concentration difficulties
Appetite change (increase or decrease)
Psychomotor agitation/retardation
Suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Self administered rating scales

A

Patient Health Questionnaire:(PHQ-9) Developed for the primary care setting
Mood Disorder Questionnaire (MDQ):Can be used to rule out bipolar disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the boxed warning risk for all antidepressant medications

A

Boxed warning for suicidality in ALL antidepressant medications (2004)
(for patients aged < 24 years of age)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the acute phase of depression treatment.

A

6-12 weeks or remission of symptoms
*Goal: induce remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the continuation phase of depression treatment

A

4-9 additional months, recommended for all patients
Goal: prevent relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the maintenance phase of depression treatment

A

Patient-specific duration Often indefinite
treatment if ≥ 3 major depressive episodes
Goal: prevent recurrence Maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are SSRIs

A

Citalopram (Celexa)
Escitalopram (Lexapro)
Fluoxetine (Prozac)
Fluvoxamine (Luvox)
Paroxetine/Paroxetine CR (Paxil)
Sertraline (Zoloft)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Citalopram (Celexa) clinical pearls

A

10-40 mg/day
>60 years: do not excess 20 mg
Dose-dependent QTc prolongation
Substrate of 2C19 and 3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Fluoxetine (Prozac) clinical pearls

A

10-80 mg/day
Long half-life (96-144 hours)
Activating potential
2D6 inhibitor, 3A4 inhibitor (norfluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fluvoxamine (Luvox) clinical pearls

A

50-300 mg/day inhibitor 1A2, 2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Paroxetine/Paroxetine CR (Paxil) clinical pearls

A

10-60 mg/day
12.5-75 mg/day
MUST taper due to anticholinergic effects
Weight gain, sedation
Septal wall defect risk to the fetus
Inhibitor 2D6, 2B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sertraline (Zoloft) clinical pearls

A

25-200 mg/day More GI upset than other antidepressant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drugs are SNRIs

A

Desvenlafaxine (Pristiq)
Duloxetine (Cymbalta)
Levomilnacipran (Fetzima)
Milnacipran (Savella)
Venlafaxine (Effexor)

15
Q

What are the adverse effects of SSRIs

A

Weight gain (paroxetine)
Weight loss (fluoxetine)
Increased bleeding risk (platelet inhibition)
Hyponatremia (especially in elderly)
Sexual dysfunction

16
Q

Desvenlafaxine (Pristiq) clinical pearls

A

Active metabolite of venlafaxine
Dose-limiting side effect: nausea
No major CYP interactions

17
Q

Duloxetine (Cymbalta) clinical pearls

A

nausea
FDA warning for hepatotoxicity
Inhibitor 2D6

18
Q

Levomilnacipran (Fetzima) clinical pearls

A

MUST adjust in renal impairment or strong 3A4 inhibitors
Substrate 3A4

19
Q

Venlafaxine (Effexor) clinical pearls

A

Must be >150 mg/day to have NE effects
2D6 inhibitor at higher doses

20
Q

SNRI adverse effects

A

blood pressure elevation and nausea useful in pain syndrome musculoskeletal pain fibromyalgia and neuropathic pain
duloxetine obtain LFTs at baseline and when symptomatic or every 6 months

21
Q

what are TCAs

A

Blockade of reuptake transporter (DAT, SERT, NET) -> inhibits the reuptake of serotonin, norepinephrine, and dopamine
Amitriptyline (Elavil) Tertiary amine

22
Q

TCAs – Adverse Effects/Key Points

A

CNS: sedation, reduced seizure threshold, confusion
Anticholinergic: blurred vision, urinary retention, constipation
Cardiovascular: orthostatic hypotension, tachycardia
Other: weight gain, sexual dysfunction
Side effects often limit higher doses:
Narrow therapeutic index: Fatal in overdose as low as 1000 mg (~4-10 tablets) due to cardiac arrhythmias or
seizures

23
Q

MAOis hypertensive Crisis

A

Tyramine diet is required with MAOis, Tyramine is degraded by monoamine oxidase → MAOis inhibit monoamine oxidase → Increase in tyramine increases blood pressure

What is included in a tyramine diet?: Smoked, aged, pickled meats or fish;
sauerkraut; aged cheeses; yeast extracts; flava beans; beer; wine

What about in small amounts? Beer, wine, avocados, meat extracts,
caffeine, chocolate

24
Q

Buporopion(wellbutrin)

A

MOA: Dopamine and norepinephrine reuptake inhibitor Stimulating – insomnia and appetite suppression
SR/XL dosing: 150-450mg/day
2D6 Inhibitor Contraindicated in active seizure disorder and eating
disorders
Can be used in combination with SSRI/SNRIs

25
Q

Mirtazapine (Remeron)

A

Sedation and increased appetite occur with doses ≤ 15 mg/day
Warnings: agranulocytosis, increased cholesterol
Can be used in combination with SSRI/SNRIs

26
Q

Trazodone (Desyrel)

A

Mechanism Selectively inhibits neuronal reuptake of serotonin and acts as an antagonist at 5HT1, 5HT2, H1 and α1
Dosing: 150-600 mg/day Higher doses needed for depression Insomnia (off-label): 50-150 mg at bedtime
Drug Interactions:
Trazodone → (3A4) →m-CPP → (2D6) →inactive metabolites
Side Effects Orthostatic hypotension Risk of priapism – medical emergency

27
Q

Vilazodone (Viibryd)

A

Primarily SSRI, may have some 5HT1a agonism which may provide anxiolytic
effects
Do not use in combination with SSRI/SNRIs
Take with food Significant nausea
Bioavailability increases with food
Substrate 3A4

28
Q

Vortioxetine (Trintellix)

A

SSRI + 5HT1A agonist + 5HT3 antagonist
Do not use in combination with SSRI/SNRIs
Possibly less sexual dysfunction
Substrate 2D6
Nausea

29
Q

Serotonin Syndrome

A

Medical emergency due to excessive amounts of serotonin in the CNS
May be caused by: Overdose Combined use of serotonergic drugs
Drug interactions
Stop the offending agent + supportive care
Potentially could use serotonin blockers
Cyproheptadine → variable efficacy
70% of patients recover within 24 hours

30
Q

Antidepressant Withdrawal syndrome

A

Common with ALL antidepressants EXCEPT fluoxetine
Antidepressants with anticholinergic activity should be tapered no matter
what

31
Q

Augmentation – Atypical Antipsychotics

A

Aripiprazole (Abilify)
* Brexpiprazole (Rexulti)
* Cariprazine (Vraylar)
* Quetiapine

32
Q

Antidepressants for PPD

A

Post-partum depression – allosteric modulator of alloprenanolone
Brexanolone – IV only, 60 hour infusion, excessive sedation boxed warning, REMS program
Zuranolone – oral dose, 14-day dosing, boxed warning for impaired driving – CNS
depression

33
Q

Antidepressants for treatment resistant depression

A

Treatment-resistant depression
Esketamine Nasal Spray – NMDA receptor antagonist
Also used for MDD with suicidal ideation
induction and maintenance phases, REMS program to give in clinic, stay in clinic for 2 hours post-
dose

34
Q

Overall Key Counseling Points

A

Abrupt discontinuation can lead to antidepressant withdrawal syndrome
Possible increase in suicidal thinking during the first few weeks of therapy

35
Q

what is Electroconvulsive Therapy (ECT)

A

Unilateral or bilateral placement of electrodes
10–15-minute procedure
Administration: 2-3 times weekly as induction, Usual course is 6-12 treatments
Continue until maximal response Can use maintenance ECT
Advantages:
Efficacy in treatment resistance, Can continue drug therapy, Age is not a factor
Safe in pregnancy
Disadvantages: Temporary memory loss Stigma
Contraindicated in recent MI or hemorrhagic stroke or if loose teeth